Cargando…

Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients

High myopia (HM) is a leading cause of mid-way blindness with a high heritability in East Asia. Although only a few disease genes have been reported, a small proportion of patients could be identified with genetic predispositions. In order to expand the mutation spectrum of the causative genes in Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Chun-Yun, Huang, Xiao-Qiong, Cheng, Xue-Wen, Wu, Rong-Han, Lu, Fan, Jin, Zi-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430800/
https://www.ncbi.nlm.nih.gov/pubmed/28442722
http://dx.doi.org/10.1038/s41598-017-01285-3
_version_ 1783236299560321024
author Feng, Chun-Yun
Huang, Xiao-Qiong
Cheng, Xue-Wen
Wu, Rong-Han
Lu, Fan
Jin, Zi-Bing
author_facet Feng, Chun-Yun
Huang, Xiao-Qiong
Cheng, Xue-Wen
Wu, Rong-Han
Lu, Fan
Jin, Zi-Bing
author_sort Feng, Chun-Yun
collection PubMed
description High myopia (HM) is a leading cause of mid-way blindness with a high heritability in East Asia. Although only a few disease genes have been reported, a small proportion of patients could be identified with genetic predispositions. In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia. Sanger sequencing was used to find possible pathogenic mutations, which were further screened in normal controls. After a pipeline of database and predictive assessments filtering, we, thereby, identified totally seven heterozygous mutations in the three genes. Among them, three novel missense mutations, c.860C > T, p.Pro287Leu and c.956G > C, p.Arg319Thr in SLC39A5, c.1982A > G, p.Lys661Arg in LEPREL1, were identified as potentially causative mutations. Additionally, the two heterozygous mutations (c.1582G > A, p.Ala528Thr; c.1982A > G, p.Lys661Arg) in one patient in LEPREL1 gene were reported in this study. Our findings will not only augment the mutation spectrum of these three genes, but also provide insights of the contribution of these genes to adult high myopia in Chinese. However, further studies are still needed to address the pathogenicity of each of the mutations reported in this study.
format Online
Article
Text
id pubmed-5430800
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54308002017-05-16 Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients Feng, Chun-Yun Huang, Xiao-Qiong Cheng, Xue-Wen Wu, Rong-Han Lu, Fan Jin, Zi-Bing Sci Rep Article High myopia (HM) is a leading cause of mid-way blindness with a high heritability in East Asia. Although only a few disease genes have been reported, a small proportion of patients could be identified with genetic predispositions. In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia. Sanger sequencing was used to find possible pathogenic mutations, which were further screened in normal controls. After a pipeline of database and predictive assessments filtering, we, thereby, identified totally seven heterozygous mutations in the three genes. Among them, three novel missense mutations, c.860C > T, p.Pro287Leu and c.956G > C, p.Arg319Thr in SLC39A5, c.1982A > G, p.Lys661Arg in LEPREL1, were identified as potentially causative mutations. Additionally, the two heterozygous mutations (c.1582G > A, p.Ala528Thr; c.1982A > G, p.Lys661Arg) in one patient in LEPREL1 gene were reported in this study. Our findings will not only augment the mutation spectrum of these three genes, but also provide insights of the contribution of these genes to adult high myopia in Chinese. However, further studies are still needed to address the pathogenicity of each of the mutations reported in this study. Nature Publishing Group UK 2017-04-25 /pmc/articles/PMC5430800/ /pubmed/28442722 http://dx.doi.org/10.1038/s41598-017-01285-3 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Feng, Chun-Yun
Huang, Xiao-Qiong
Cheng, Xue-Wen
Wu, Rong-Han
Lu, Fan
Jin, Zi-Bing
Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title_full Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title_fullStr Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title_full_unstemmed Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title_short Mutational screening of SLC39A5, LEPREL1 and LRPAP1 in a cohort of 187 high myopia patients
title_sort mutational screening of slc39a5, leprel1 and lrpap1 in a cohort of 187 high myopia patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430800/
https://www.ncbi.nlm.nih.gov/pubmed/28442722
http://dx.doi.org/10.1038/s41598-017-01285-3
work_keys_str_mv AT fengchunyun mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients
AT huangxiaoqiong mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients
AT chengxuewen mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients
AT wuronghan mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients
AT lufan mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients
AT jinzibing mutationalscreeningofslc39a5leprel1andlrpap1inacohortof187highmyopiapatients